On November 18, 2026, nine insiders at Roivant Sciences Ltd. (ROIV) executed a series of sales, divesting shares valued at approximately $140.28 million. The transactions involved multiple sales at varying price points, including significant blocks sold by Financial Lp Qvt, Daniel Allen Gold, and Keith S. Manchester.
These sales occurred over a period of time, with different tranches of shares being sold at prices ranging from $38.24 to $39.17 per share. The aggregated value of these transactions represents a substantial disposition of stock by individuals associated with the company.
While insider selling can be attributed to various personal financial activities such as portfolio diversification or tax planning, a coordinated sale involving multiple insiders may draw investor attention. The specific motivations behind these particular transactions were not disclosed.